Contact
searchSearch
HMP Global

News

AML TUMORS
Fluidx Medical Announces First Patient Treated with Novel Embolic Gel
04/01/2026
Gel embolic device designed to simplify the embolization procedure and reduce risks to the patient. 
Gel embolic device designed to simplify the embolization procedure and reduce risks to the patient. 
Gel embolic device designed to...
04/01/2026
Vascular Disease Management
Acute Pulmonary Embolism
HI-PEITHO Trial Demonstrates Boston Scientific EKOS™ Endovascular System Is Superior to Standard of Care for Treatment of Acute Pulmonary Embolism
04/01/2026
Global randomized trial demonstrated statistically significant reduction in clinical event rates in patients with intermediate-risk PE when treated with the EKOS device plus anticoagulation vs. anticoagulation alone Late breaking findings...
Global randomized trial demonstrated statistically significant reduction in clinical event rates in patients with intermediate-risk PE when treated with the EKOS device plus anticoagulation vs. anticoagulation alone Late breaking findings...
Global randomized trial...
04/01/2026
Vascular Disease Management
PROTECT H2H global clinical trial
Emboline Announces Positive Pivotal PROTECT H2H Trial Results for Emboliner® Presented as a Late-Breaking Clinical Trial at ACC 2026
03/31/2026
Randomized IDE study met all primary and secondary safety and efficacy endpoints and demonstrated superior debris capture and significantly higher technical success versus the leading embolic protection control device in TAVR SANTA CRUZ,...
Randomized IDE study met all primary and secondary safety and efficacy endpoints and demonstrated superior debris capture and significantly higher technical success versus the leading embolic protection control device in TAVR SANTA CRUZ,...
Randomized IDE study met all...
03/31/2026
Vascular Disease Management
Drug-Coated Balloons
SirPAD: Primary Results Confirm the Safety and Efficacy of Sirolimus Coated Balloon in PAD
03/31/2026
Tampa, Florida – Concept Medical Inc. (CMI), a global leader in innovative drug-delivery technology across vascular interventions, proudly announces the presentation of the world’s largest randomised controlled trial of a Sirolimus-coated...
Tampa, Florida – Concept Medical Inc. (CMI), a global leader in innovative drug-delivery technology across vascular interventions, proudly announces the presentation of the world’s largest randomised controlled trial of a Sirolimus-coated...
Tampa, Florida – Concept Medical...
03/31/2026
Vascular Disease Management
Interventional Cardiology
Philips Launches IntraSight Plus to Simplify Coronary Interventions and Advance Precision Care
03/25/2026
Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools to help support confident decisions and improved patient care With FDA clearance and CE marking, IntraSight Plus...
Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools to help support confident decisions and improved patient care With FDA clearance and CE marking, IntraSight Plus...
Intuitive interventional...
03/25/2026
Vascular Disease Management
Blunt Thoracic Aortic Injury
Society for Vascular Surgery Releases Clinical Practice Guideline on the Management of Blunt Thoracic Aortic Injury
03/24/2026
Updated guidance incorporates new research to address non-operative management of BTAI, timing of repair and the management of patients with concomitant traumatic injuries.
Updated guidance incorporates new research to address non-operative management of BTAI, timing of repair and the management of patients with concomitant traumatic injuries.
Updated guidance incorporates...
03/24/2026
Vascular Disease Management
Endovascular Devices
Thrombolex, Inc. Secures $50 Million Series A Growth Financing to Advance Commercialization of its Innovative Pharmaco-Mechanical Lysis Technology (PML)
03/19/2026
New Britain, PA, March 16, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...
New Britain, PA, March 16, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...
New Britain, PA, March 16, 2026...
03/19/2026
Vascular Disease Management
Neurovascular Care
Medtronic to Acquire Scientia Vascular, Marrying Access and Therapeutic Portfolios for Neurovascular Care
03/10/2026
Deal complements Medtronic's Neurovascular portfolio, delivering simplicity and access when 'time is brain'.
Deal complements Medtronic's Neurovascular portfolio, delivering simplicity and access when 'time is brain'.
Deal complements Medtronic's...
03/10/2026
Vascular Disease Management
VDM logo
Analysis
Artificial Intelligence Advances in Interventional Oncology: Year in Review
02/23/2026
Laura Simson, MA
02/23/2026
Vascular Disease Management
New Stroke Guidelines
New Guideline Expands Stroke Treatment for Adults, Offers First Pediatric Stroke Guidance
02/19/2026
Updated ischemic stroke recommendations from the American Stroke Association highlight how rapid diagnosis and imaging, extended time windows for stroke treatments and coordinated care involving emergency services, hospitals and health care...
Updated ischemic stroke recommendations from the American Stroke Association highlight how rapid diagnosis and imaging, extended time windows for stroke treatments and coordinated care involving emergency services, hospitals and health care...
Updated ischemic stroke...
02/19/2026
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

AML TUMORS
Fluidx Medical Announces First Patient Treated with Novel Embolic Gel
04/01/2026
Gel embolic device designed to simplify the embolization procedure and reduce risks to the patient. 
Gel embolic device designed to simplify the embolization procedure and reduce risks to the patient. 
Gel embolic device designed to...
04/01/2026
Vascular Disease Management
Acute Pulmonary Embolism
HI-PEITHO Trial Demonstrates Boston Scientific EKOS™ Endovascular System Is Superior to Standard of Care for Treatment of Acute Pulmonary Embolism
04/01/2026
Global randomized trial demonstrated statistically significant reduction in clinical event rates in patients with intermediate-risk PE when treated with the EKOS device plus anticoagulation vs. anticoagulation alone Late breaking findings...
Global randomized trial demonstrated statistically significant reduction in clinical event rates in patients with intermediate-risk PE when treated with the EKOS device plus anticoagulation vs. anticoagulation alone Late breaking findings...
Global randomized trial...
04/01/2026
Vascular Disease Management
PROTECT H2H global clinical trial
Emboline Announces Positive Pivotal PROTECT H2H Trial Results for Emboliner® Presented as a Late-Breaking Clinical Trial at ACC 2026
03/31/2026
Randomized IDE study met all primary and secondary safety and efficacy endpoints and demonstrated superior debris capture and significantly higher technical success versus the leading embolic protection control device in TAVR SANTA CRUZ,...
Randomized IDE study met all primary and secondary safety and efficacy endpoints and demonstrated superior debris capture and significantly higher technical success versus the leading embolic protection control device in TAVR SANTA CRUZ,...
Randomized IDE study met all...
03/31/2026
Vascular Disease Management
Drug-Coated Balloons
SirPAD: Primary Results Confirm the Safety and Efficacy of Sirolimus Coated Balloon in PAD
03/31/2026
Tampa, Florida – Concept Medical Inc. (CMI), a global leader in innovative drug-delivery technology across vascular interventions, proudly announces the presentation of the world’s largest randomised controlled trial of a Sirolimus-coated...
Tampa, Florida – Concept Medical Inc. (CMI), a global leader in innovative drug-delivery technology across vascular interventions, proudly announces the presentation of the world’s largest randomised controlled trial of a Sirolimus-coated...
Tampa, Florida – Concept Medical...
03/31/2026
Vascular Disease Management
Interventional Cardiology
Philips Launches IntraSight Plus to Simplify Coronary Interventions and Advance Precision Care
03/25/2026
Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools to help support confident decisions and improved patient care With FDA clearance and CE marking, IntraSight Plus...
Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools to help support confident decisions and improved patient care With FDA clearance and CE marking, IntraSight Plus...
Intuitive interventional...
03/25/2026
Vascular Disease Management
Blunt Thoracic Aortic Injury
Society for Vascular Surgery Releases Clinical Practice Guideline on the Management of Blunt Thoracic Aortic Injury
03/24/2026
Updated guidance incorporates new research to address non-operative management of BTAI, timing of repair and the management of patients with concomitant traumatic injuries.
Updated guidance incorporates new research to address non-operative management of BTAI, timing of repair and the management of patients with concomitant traumatic injuries.
Updated guidance incorporates...
03/24/2026
Vascular Disease Management
Endovascular Devices
Thrombolex, Inc. Secures $50 Million Series A Growth Financing to Advance Commercialization of its Innovative Pharmaco-Mechanical Lysis Technology (PML)
03/19/2026
New Britain, PA, March 16, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...
New Britain, PA, March 16, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...
New Britain, PA, March 16, 2026...
03/19/2026
Vascular Disease Management
Neurovascular Care
Medtronic to Acquire Scientia Vascular, Marrying Access and Therapeutic Portfolios for Neurovascular Care
03/10/2026
Deal complements Medtronic's Neurovascular portfolio, delivering simplicity and access when 'time is brain'.
Deal complements Medtronic's Neurovascular portfolio, delivering simplicity and access when 'time is brain'.
Deal complements Medtronic's...
03/10/2026
Vascular Disease Management
VDM logo
Analysis
Artificial Intelligence Advances in Interventional Oncology: Year in Review
02/23/2026
Laura Simson, MA
02/23/2026
Vascular Disease Management
New Stroke Guidelines
New Guideline Expands Stroke Treatment for Adults, Offers First Pediatric Stroke Guidance
02/19/2026
Updated ischemic stroke recommendations from the American Stroke Association highlight how rapid diagnosis and imaging, extended time windows for stroke treatments and coordinated care involving emergency services, hospitals and health care...
Updated ischemic stroke recommendations from the American Stroke Association highlight how rapid diagnosis and imaging, extended time windows for stroke treatments and coordinated care involving emergency services, hospitals and health care...
Updated ischemic stroke...
02/19/2026
Vascular Disease Management

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use